UNSPSC 51383509: Ketorolac trometamol

This classification denotes a cyclooxygenase inhibitor with the molecular formula C15H13NO3.C4H11NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4EVE5946BQ, chemically known as 1h-pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro, (+-)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1) but more generally known as ketorolac trometamol, which bears US NIH Compound Identifier 84003.

European Medicines Agency schedules Ketorolac trometamol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02835MIG. Most nations, for tariff and trade purposes, schedule ketorolac trometamol under HS 29339990. SMILES: C1CCC(CC1)C(=O)C2CCC3N2CCC3C(=O)O.C(C(CO)(CO)N)O.

UNSPSC 51383509 Ketorolac trometamol is a Commodity code that does not align with the recent state and local procurement activity posted under it. The three most recent opportunities tagged to this code involve naloxone and safe drug deactivation systems (Seminole County, Florida), direct-to-manufacturer pharmacy benefit programs (Texas Health and Human Services Commission), and multi-source generic pharmaceuticals and OTC products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations seek ketorolac trometamol or nonsteroidal anti-inflammatory drugs; the code shows little relevant recent activity.

The geographic spread of recent opportunities spans Florida, Texas, and Minnesota, reflecting activity across state health agencies, county health departments, and cooperative purchasing vehicles. If ketorolac trometamol procurement occurs under this code in state and local markets, it is not currently visible in the recent opportunities stream. Business development professionals should verify whether state and local buyers are tagging ketorolac solicitations to this code or whether the code has drifted from its intended scope in the procurement systems being monitored.